Key Events This Week
30 Mar: New 52-week low at Rs.150.65 amid ongoing downtrend
1 Apr: Strong gap up and intraday high of Rs.159 with 7.41% gain
2 Apr: Modest gain to close at Rs.160.70, consolidating weekly rebound
May 07
BSE+NSE Vol: 5.18 lacs

The Sensex edged up a modest 0.14% on 6 May 2026, but Hikal Ltd surged 7.22%, outperforming its Pharmaceuticals & Biotechnology sector by nearly 5 percentage points. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a steady upward trajectory over the past week.
Read full news article
Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent uptick in price, the company’s overall technical indicators and fundamental metrics suggest caution for investors navigating this volatile landscape.
Read full news article
Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined by 2.94% today, reflecting growing investor caution amid mixed technical signals and a deteriorating overall outlook.
Read full news article
Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Hikal Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent 2.29% rise in its share price to ₹187.30, the company’s overall technical and fundamental outlook remains cautious, with a MarketsMOJO Mojo Grade downgraded to Strong Sell as of 14 Nov 2025.
Read full news article
Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
30 Mar: New 52-week low at Rs.150.65 amid ongoing downtrend
1 Apr: Strong gap up and intraday high of Rs.159 with 7.41% gain
2 Apr: Modest gain to close at Rs.160.70, consolidating weekly rebound

Hikal Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleHikal Limited with respect to announcement dated 28-Oct-2019, regarding 'Update on plant operations of the Company'. On basis of above the Company is required to clarify following: 1. The actual amount of damage caused due to the natural calamity or other force majeure events; 2. Details of steps taken to restore normalcy and the impact of the natural calamity/other force majeure events on production or service, financials of the entity The response of the Company is attached
Hikal Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
| Hikal Limited has informed the Exchange with copy of minutes of Annual General Meeting held on August 01, 2019 |
No Upcoming Board Meetings
Hikal Ltd has declared 10% dividend, ex-date: 17 Feb 26
Hikal Ltd has announced 2:10 stock split, ex-date: 27 Feb 15
Hikal Ltd has announced 1:2 bonus issue, ex-date: 22 Jun 18
No Rights history available